NCT02499952 2022-07-11
Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Hoosier Cancer Research Network
Phase 2 Terminated
Hoosier Cancer Research Network
Dana-Farber Cancer Institute
Stanford University
Auron Healthcare GmbH